← Back to Screener
Sunshine Biopharma Inc. warrant (SBFMW)
Price$0.07
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-80.76%
Price vs S&P 500 (4W)-22.25%
VGM Score5.33
All Metrics
Price vs S&P 500 (YTD)-72.59%
10-Day Avg Trading Volume0.02M
3-Month Avg Trading Volume0.01M
52-Week High$0.65
26-Week Price Return-64.83%
13-Week Price Return-61.48%
3-Month Return Std Dev317.59%
Year-to-Date Return-57.42%
5-Day Price Return-37.72%
Month-to-Date Return-41.80%
Price vs S&P 500 (13W)-71.22%
Beta0.64x
52-Week Low$0.05
mGradeF
vgmGradeF
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SBFMWSunshine Biopharma Inc. warrant | — | — | F | $0.07 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
Sunshine Biopharma is a pharmaceutical company with established operations in generic prescription drugs and OTC supplements, primarily in Canada. The company is advancing a proprietary drug development pipeline focused on oncology and infectious disease, including K1.1 mRNA for liver cancer and SBFM-PL4, a protease inhibitor for SARS-CoV-2. This dual approach combines steady revenue from existing products with potential growth from pipeline programs.